iRhythm pre-announces FY2024 revenue above guidance; FY2025 outlook $675M-$685M

iRhythm Holdings, Inc.

FY2024 revenue expected slightly above prior guidance of $587.5M (provided Oct 2024).
FY2025 revenue guidance of $675M-$685M, representing ~15% growth at midpoint.
Record Q4 new account openings for Zio monitor and Zio AT; strong national account volumes.
First four health systems launched on Epic Aura in Q4 2024; commercial rollout for Epic systems starts 2025.
Began Zio monitor shipments for home enrollment patients in Q4 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.